• Home
  • >>>>>>>>>>>>> 2026 & BEYOND MASTER PLAN >>>>>>>>>>>>>>>>
  • TRAINABLE DATA ASSETS IN CORPORATE LEGACY & ORGANIZATION’s STRATEGIC MEMORY (2012 – 2025)
  • 2.0 LPBI Executive Summary
  • 1.0 LPBI Executive Summary
  • Founder’s Vision
  • Portfolio of IP Assets
  • Knowledge PORTALS System (KPS)
  • 1.0 LPBI – 2012-2020 VISTA
  • LPBI Group’s History
  • 2.0 LPBI – 2021-2025 VISION
  • BioMed e-Series
  • Press Coverage
  • Investor Relations
  • Our TEAM
  • Founder’s Bio
  • Funding, Deals & Partnerships
  • 1.0 LPBI Group News
  • 1.0 LPBI CALENDAR
  • 2.0 LPBI Group News
  • Testimonials about LPBI
  • DrugDiscovery @LPBI Group
  • Medical 3D Printing
  • e-VOICES Podcasting
  • LPBI Newsletters
  • Customer Surveys
  • Health Care INVESTOR’s Corner ($)
  • 2021 Summer Internship Portal
  • 2021-2025 Medical Text Analysis (NLP)
  • Artificial Intelligence: Genomics & Cancer
  • Blockchain Transactions Network Ecosystem
  • 1.0 LPBI Brochure
  • 2.0 LPBI Brochure
  • 2.0 LPBI – Calendar of Zooms
  • Coronavirus, SARS-CoV-2 Portal
  • LPBI India
  • SOP Web STAT
  • Synthetic Biology in Drug Discovery
  • Certificate One Year
  • NFT: Redefined Format of IP Assets
  • Audio English-Spanish: BioMed e-Series
  • Five Bilingual BioMed e-Series
  • Press Releases
  • Intangibles CIM
  • BioMed Audio Podcast Library @LPBI Group
  • Medical School Education: Use of LPBI Group’s Contents
  • ChatGPT + Wolfram PlugIn
  • Medicine with GPT-4 & ChatGPT
  • AGI, generativeAI, Grok, DeepSeek & Expert Models in Healthcare
  • Multimodal Healthcare Foundation Model
  • Cell Therapy in Regenerative Medicine, 2026 and Beyond
  • Contact Us

Leaders in Pharmaceutical Business Intelligence Group, LLC, Doing Business As LPBI Group, Newton, MA

Healthcare analytics, AI solutions for biological big data, providing an AI platform for the biotech, life sciences, medical and pharmaceutical industries, as well as for related technological approaches, i.e., curation and text analysis with machine learning and other activities related to AI applications to these industries.

Feeds:
Posts
Comments

TEAM PRESENTATIONS: 8/2015 – 12/2015

Schedule of Presentations Delivered

8/2015 – 12/2015

#1: date: 8/13/2015 

Presenter: Aviva

Topic: Medical 3D Printing Applications & Technologies, Tools & Processing

LPBI’s Perspective on Medical and Life Sciences Applications – 3D Printing: BioInks, BioMaterials-BioPolymer

http://pharmaceuticalintelligence.com/2015/08/12/lpbis-perspective-on-medical-and-life-sciences-applications-3d-printing-bioinks-biomaterials-biopolymer/

LPBI’s Perspective on Technologies Platforms & Tools in the Production and Process Control of Components & Systems using BioMaterials, BioPrinting and BioFabrication

http://pharmaceuticalintelligence.com/2015/08/12/lpbis-perspective-on-technologies-platforms-tools-in-the-production-and-process-control-of-components-systems-using-biomaterials-bioprinting-and-biofabrication/

 

#2: date: 8/20/2015 

Presenter: Steve Lerner

Topic: Medical 3D Printing & Programmable Sensors

#3: date: 8/27/2015 

Presenter: Dr. Pearlman

Topic: Medical 3D Printing: Thought Leadership for Products and Services

#4: date: 9/3/2015 

Presenter: Dr. Stephen J Williams

Topic: Medical 3D Printing and BioInks

http://pharmaceuticalintelligence.com/2016/04/04/bio-inks-and-3d-bioprinting/

#5: date: 9/10/2015 – Aviva’s Presentation

AGENDA for 9/10

  • GDE

http://pharmaceuticalintelligence.com/gama-delta-epsilon-gde-is-a-global-holding-company-absorbing-lpbi/

  • Matrix Organization for M3DP

http://pharmaceuticalintelligence.com/2015/08/26/lpbis-m3dp-matrix-organization/

#6: date: 9/24/2015 

Presenter: Irina Robu, PhD

Topic: Medical 3D Printing for Tissue Engineering 

#7: date: 10/1/2015 

Topic: Presenter: Irina Robu, PhD

Medical 3D Printing for Tissue Engineering

#8: date: 10/8/2015 

Presenter: Bill Zurn

Topic: Medical 3D Printing and MEMS 

#9: date: 10/15/2015 

Presenter: Tilda Barliya, PhD

Topic: Medical 3D Printing and Tissue Engineering in Israel 

#9A: date: 10/16/2015 THREE Presentations 

Presentation #1: Rosalind Codrington, PhD – 60 minutes

Cell Selection using Intracellular Targets

Presentation #2: Evelyna Cohn, PhD – 30 – minutes

Glycoprotein and 3D BioPrinting

Presentation #3: Stephen J Williams, PhD and Dharmendra Goswami, PhD – 30 Minutes

Gene Therapy: CRISPR and 3D BioPrinting

#10: date: 10/22/2015 

Presenter: Danut Dragoi

Topic: Medical 3D Printing and Metals in use in Medical Devices 

#11: date: 10/29/0215 

Presenter: Gerard Loiseau

Topic: Medical 3D Printing and Dental 

#12: date: 11/5/2015 

Presenter: Dr. Raphael Nir

Topic: Medical 3D Printing and Cytokines 

#13: date: 11/12/2015 

Presenter: Dr. Dharmendra Goswami

Topic: CRISPR and The Future of Gene Therapy

#14: date 11/19/2015 

Presenter: Rosalind Codrington, PhD – 60 minutes

Topic: Immunology, Magnetic Beads and 3D BioPrinting

Share this:

  • Share on X (Opens in new window) X
  • Share on LinkedIn (Opens in new window) LinkedIn
  • Share on Facebook (Opens in new window) Facebook
  • Print (Opens in new window) Print
  • Email a link to a friend (Opens in new window) Email

Like this:

Like Loading…

  • Follow Blog via Email

    Enter your email address to follow this blog and receive notifications of new posts by email.

    Join 2,064 other subscribers
  • Recent Posts

    • In Memoriam: Professor Yitzhak Apeloig, President and Distinguised Professor of the Technion June 4, 2026
    • Top VC Investors in AI / Health AI in 2026 May 26, 2026
    • Grok thinks like PhDs – Hybrid Model for Autonomous Update of Doctoral Dissertations with Original PhD Student Author editing and acceptance of Grok’s updated output. 3rd Joint article, a pilot study for Validation of an Autonomous Journal Articles Updating System (AJAUS) tested on Autonomous Update of Aviva Lev-Ari, PhD, RN Doctoral Thesis, UC, Berkeley, 1983. January 31, 2026
    • 2026 World Economic Forum, 1/19 – 1/23/2026, Davos, Switzerland, LPBI Group’s KOLs interpretation of AI in Health Videos January 24, 2026
    • Evolving LPBI Group’s Portfolio of Intellectual Properties (IP): From 2021 Vision to 2026 Reality January 12, 2026
    • Aviva Lev-Ari, PhD, RN – Biography ->> Grokepedia Entry January 11, 2026
    • List of Articles included in the Article SELECTION from Collection of Aviva Lev-Ari, PhD, RN Scientific Articles on PULSE on LinkedIn.com for Training Small Language Models (SLMs) in Domain-aware Content of Medical, Pharmaceutical, Life Sciences and Healthcare by 15 Subjects Matter January 10, 2026
    • Article SELECTION from Collection of Aviva Lev-Ari, PhD, RN Scientific Articles on PULSE on LinkedIn.com for Training Small Language Models (SLMs) in Domain-aware Content of Medical, Pharmaceutical, Life Sciences and Healthcare by 15 Subjects Matter January 10, 2026
    • Collection of Aviva Lev-Ari, PhD, RN Scientific Articles on PULSE on LinkedIn.com January 10, 2026
    • The youngest leader in AI in Health: Tanishq Mathew Abraham, Ph.D. (@iScienceLuvr) January 8, 2026
  • Archives

  • Categories

  • Meta

    • Log in
    • Entries feed
    • Comments feed
    • WordPress.org
    • 1 2012pharmaceutical
    • 1 sjwilliamspa

Powered by WordPress.com.

WPThemes.


%d